secwatch.observer — SEC 8-K summary
======================================

Issuer:     AtriCure, Inc. (ATRC)
CIK:        0001323885
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001323885-25-000002
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AtriCure reports preliminary Q4 revenue $124.3M (+17%); guides 2025 revenue $517-527M
--------------------------------------------------------------------------------

- Preliminary Q4 2024 revenue $124.3M (+17% YoY as reported and constant currency).
- U.S. revenue $101.6M (+14%), international $22.7M (+28%) in Q4.
- FY2024 revenue $465.3M (+17%); expects adj. EBITDA $26M-$29M and adj. EPS loss $0.74-$0.80.
- 2025 guidance: revenue $517M-$527M, adj. EBITDA $40M-$44M, modest cash flow generation.
- Analyst & Investor Day scheduled for March 26, 2025 at Mason, Ohio headquarters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1323885/000132388525000002/0001323885-25-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1323885/000132388525000002/atrc-20250113.htm
  HTML page:      https://secwatch.observer/filing/0001323885-25-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer